ATTICUS WEALTH MANAGEMENT, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
ATTICUS WEALTH MANAGEMENT, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$11,000
+83.3%
500.0%0.01%
+66.7%
Q4 2020$6,000
+20.0%
500.0%0.00%0.0%
Q3 2020$5,000
-16.7%
500.0%0.00%
-25.0%
Q2 2020$6,000
+50.0%
500.0%0.00%
+33.3%
Q1 2020$4,000500.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders